Jun Gu

5.4k citations

123 papers · 3.8k indexed · 1 hit paper · h-index 39

Impact in

Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Geriatrics and Gerontology top 2%

Papers in ⓘ

Cardiology and Cardiovascular Medicine 25
- Atrial Fibrillation Management and Outcomes 10
- Chemotherapy-induced cardiotoxicity and mitigation 7
Molecular Biology 65
- Epigenetics and DNA Methylation 9
- Cell death mechanisms and regulation 9
- Cancer-related gene regulation 8

Co-authors: Changqian Wang (12 shared papers)Jianguo Chen (8 shared papers)Yingbin Liu (26 shared papers)Wei Hu (6 shared papers)Jianan Pan (9 shared papers)Junfeng Zhang (9 shared papers)Fang Wang (6 shared papers)Ping Dong (14 shared papers)
Journals: Cell Research (3 papers)Cancer Letters (3 papers)Frontiers in Cardiovascular Medicine (3 papers)Clinical Epigenetics (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)
Partner nations: China United States Sweden

In The Last Decade

Jun Gu

119 papers receiving 3.8k citations

Hit Papers

align trajectories log scale

Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells 2021 · 142 citations

Peers

Countries citing papers authored by Jun Gu

Since Specialization

Citations

This map shows the geographic impact of Jun Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Gu more than expected).

Fields of papers citing papers by Jun Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Gu. The network helps show where Jun Gu may publish in the future.

Co-authors

The 25 scholars most cited alongside Jun Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jun Gu Line = papers co-authored together Jun Gu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-κB pathways and inhibition of intracellular ROS/RNS generation Free Radical Biology and Medicine ·Ting Wang, Jun Gu, Pengfei Wu, Fang Wang, Xiong Zhe, Yuan‐Jian Yang, Wen‐Ning Wu, Ling-Dan Dong, Jianguo Chen	2009	199
2	Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells Redox Biology ·Jianan Pan, Hui Zhang, Hao Lin, Lin Gao, Huili Zhang, Junfeng Zhang, Changqian Wang, Jun Gu Hit paper breakdown →	2021	142
3	Neuroprotection by baicalein in ischemic brain injury involves PTEN/AKT pathway Journal of Neurochemistry ·Chao Liu, Jiliang Wu, Kui Xu, Fei Cai, Jun Gu, Liqun Ma, Jianguo Chen	2009	135
4	Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS/JNK-dependent mitochondrial pathway Cancer Letters ·Songgang Li, Ping Dong, Jianwei Wang, Jie Zhang, Jun Gu, Xiangsong Wu, Wenguang Wu, Xiaozhou Fei, Zhiping Zhang, Yong Wang, Zhiwei Quan, Yingbin Liu	2010	134
5	Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma BMC Cancer ·Jian Yu, Hongyu Zhang, Jun Gu, Song Lin, Junhua Li, Wei Lu, Yifei Wang, Jingde Zhu	2004	100
6	Hypomethylation of the hsa-miR-191 Locus Causes High Expression of hsa-miR-191 and Promotes the Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Neoplasia ·Yinghua He, Ying Cui, Wei Wang, Jun Gu, Shicheng Guo, Kelong Ma, Xiaoying Luo	2011	95
7	miR-146a attenuates apoptosis and modulates autophagy by targeting TAF9b/P53 pathway in doxorubicin-induced cardiotoxicity Cell Death and Disease ·Jianan Pan, Yong Tang, Jianying Yu, Hui Zhang, Junfeng Zhang, Changqian Wang, Jun Gu	2019	93
8	Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts Experimental Cell Research ·Jun Gu, Xu Liu, Quanxing Wang, Hong‐Wei Tan, Meng Guo, Weifeng Jiang, Li Zhou	2012	86
9	Baicalein improves cognitive deficits induced by chronic cerebral hypoperfusion in rats Pharmacology Biochemistry and Behavior ·Chao Liu, Jiliang Wu, Jun Gu, Zhe Xiong, Fang Wang, Jian‐Zhi Wang, Wei Wang, Jianguo Chen	2007	84
10	Resveratrol suppresses doxorubicin-induced cardiotoxicity by disrupting E2F1 mediated autophagy inhibition and apoptosis promotion Biochemical Pharmacology ·Jun Gu, Yuqi Fan, Huili Zhang, Jianan Pan, Jianying Yu, Junfeng Zhang, Changqian Wang	2018	83
11	Evaluation of Two Inflammation-Based Prognostic Scores in Patients with Resectable Gallbladder Carcinoma Annals of Surgical Oncology ·Xiangsong Wu, Liubin Shi, Maolan Li, Qian Ding, Hao Weng, Wenguang Wu, Yang Cao, Runfa Bao, Yijun Shu, Qichen Ding, Jiasheng Mu, Jun Gu, Ping Dong, Yingbin Liu	2013	79
12	Rapamycin Inhibits Cardiac Hypertrophy by Promoting Autophagy via the MEK/ERK/Beclin-1 Pathway Frontiers in Physiology ·Jun Gu, Wei Hu, Zhiping Song, Yueguang Chen, Dadong Zhang, Changqian Wang	2016	77
13	Antidepressant Effects of a Plant-Derived Flavonoid Baicalein Involving Extracellular Signal-Regulated Kinases Cascade Biological and Pharmaceutical Bulletin ·Zhe Xiong, Bo Jiang, Pengfei Wu, Jia Tian, Liangliang Shi, Jun Gu, Zhuang‐Li Hu, Hui Fu, Fang Wang, Jianguo Chen	2011	77
14	Reactive oxygen species-mediated endoplasmic reticulum stress and mitochondrial dysfunction contribute to cirsimaritin-induced apoptosis in human gallbladder carcinoma GBC-SD cells Cancer Letters ·Zhiwei Quan, Jun Gu, Ping Dong, Jianhua Lu, Xiangsong Wu, Wenguang Wu, Xiaozhou Fei, Songgang Li, Yong Wang, Jianwei Wang, Yingbin Liu	2010	76
15	Resveratrol-induced autophagy promotes survival and attenuates doxorubicin-induced cardiotoxicity International Immunopharmacology ·Jun Gu, Wei Hu, Zhiping Song, Yueguang Chen, Dadong Zhang, Changqian Wang	2016	73
16	Dioscin Induces Gallbladder Cancer Apoptosis by Inhibiting ROS-Mediated PI3K/AKT Signalling International Journal of Biological Sciences ·Xiaoling Song, Zheng Wang, Haibin Liang, Wenjie Zhang, Yuanyuan Ye, Huaifeng Li, Yunping Hu, Yijian Zhang, Hao Weng, Jianhua Lu, Xuefeng Wang, Maolan Li, Yingbin Liu, Jun Gu	2017	72
17	Beneficial effect of pioglitazone on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus EP Europace ·Jun Gu, Xiaobing Liu, Xinhua Wang, Haifeng Shi, Hongyu Tan, Li Zhou, Jun Gu, Weifeng Jiang, Yan Wang	2011	65
18	Sinomenine protects against ischaemic brain injury: involvement of co-inhibition of acid-sensing ion channel 1a and L-type calcium channels British Journal of Pharmacology ·Wen‐Ning Wu, Pengfei Wu, Xiang‐Long Chen, Zui Zhang, Jun Gu, Yuan‐Jian Yang, Qiuju Xiong, Lan Ni, Fang Wang, Jianguo Chen	2011	63
19	Resveratrol, a polyphenol phytoalexin, protects against doxorubicin‐induced cardiotoxicity Journal of Cellular and Molecular Medicine ·Jun Gu, Wei Hu, Dadong Zhang	2015	63
20	Loss of miR-638 in vitro promotes cell invasion and a mesenchymal-like transition by influencing SOX2 expression in colorectal carcinoma cells Molecular Cancer ·Kelong Ma, Xiaorong Pan, Pingsheng Fan, Yinghua He, Jun Gu, Wei Wang, Tengyue Zhang, Zonghai Li, Xiaoying Luo	2014	62

About Jun Gu

Jun Gu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Cancer Research, Physiology and Geriatrics and Gerontology, having authored 123 papers that have together received 3.8k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (10 papers), Epigenetics and DNA Methylation (9 papers), Cell death mechanisms and regulation (9 papers), Cancer-related gene regulation (8 papers), Autophagy in Disease and Therapy (7 papers), Gallbladder and Bile Duct Disorders (7 papers), Chemotherapy-induced cardiotoxicity and mitigation (7 papers) and Pancreatic and Hepatic Oncology Research (6 papers). The work is most often cited by research in Cancer Research (634 citations), Geriatrics and Gerontology (130 citations), Cardiology and Cardiovascular Medicine (643 citations), Molecular Biology (1.9k citations) and Neurology (216 citations). Jun Gu has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Changqian Wang, Jianguo Chen, Yingbin Liu, Wei Hu, Jianan Pan, Junfeng Zhang, Fang Wang, Ping Dong, Xiangsong Wu and Jianhua Lu. Their work appears in journals such as Cell Research, Cancer Letters, Frontiers in Cardiovascular Medicine, Clinical Epigenetics and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact